REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive Therapy
Clinical trial NCT04409080 · TERMINATED
Trial details
- NCT number
- NCT04409080
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-13
- Primary completion
- 2024-10-17
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.